Another validation to TLN research
CIV infusion for temozolomide
https://www.hemonctoday.com/article.aspx?rid=37616
TLN scientists have done a pretty impressive work. CIV was critiezed but turns out it is probably the best delivery option for GBM drugs.
Now, no dosage limitation.
480 mg is beyond therapeutic level needed.
GBM cells are flooded with 4601 - maximum efficacy expected.